TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer-Reference-Cited by-同舟云学术

TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer

Published:2011-02-22 Issue:5 Volume:71 Page:1607-1614
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Salaun Bruno,Zitvogel Laurence,Asselin-Paturel Carine,Morel Yannis,Chemin Karine,Dubois Clarisse,Massacrier Catherine,Conforti Rosa,Chenard Marie Pierre,Sabourin Jean-Christophe,Goubar Aicha,Lebecque Serge,Pierres Michel,Rimoldi Donata,Romero Pedro,Andre Fabrice

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma;Molecular and Cellular Probes;2024-06

2. Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy;Journal for ImmunoTherapy of Cancer;2024-05

3. Deciphering the role of TLR3 polymorphisms in oral squamous cell carcinoma pathogenesis: A case-control study;Journal of Oral and Maxillofacial Pathology;2024-04

4. Exploring the underlying correlation between microbiota, immune system, hormones, and inflammation with breast cancer and the role of probiotics, prebiotics and postbiotics;Archives of Microbiology;2024-03-10

5. The immunostimulant effects of the rice ragged stunt virus genome on the growth and metastasis of breast cancer in mouse model;International Immunopharmacology;2023-12